Trastuzumab Deruxtecan in Advanced Breast Cancer

NCT07180264 · clinicaltrials.gov ↗

RECRUITING

Status

118

Enrollment

OTHER

Sponsor class

Conditions

Advanced Breast Cancer

Interventions

DRUG: Trastuzumab deruxtecan

Sponsor

Wenjin Yin